Cancer BiologybioRxivPreprint
Targeting ribosome biogenesis sensitizes PARPi-resistant triple-negative breast cancer
Mallory I. Frederick, Nicolas Pouderous, Kenan Aloss…·Saima Noor Hassan
This study shows that combining PARPi with ribosome biogenesis inhibitors sensitizes PARPi-resistant triple-negative breast cancer cells and identifies ribosome biogenesis as a therapeutic target.
DOI 10.64898/2026.10.08.757577